The Children’s Cancer Project
Fullfilling the National Cancer Center’s desire to provide funds for pediatric cancer research and education, we created the Children’s Cancer Project to investigate prevention and treatment of pediatric oncology, as well as public education relating to detection.
Our fellowship to Children’s Hospital of Philadelphia focuses on neuroblastoma, the most common solid tumor cancer found in children.
Current Grants and Renewals
National Cancer Center has been proud to award grants to many fine research organizations.
We know that a cure lies in research and we are committed to supporting as many research projects as we can.
Guimei Jiang, Ph.D.
NY University, New York, NY PROJECT: Use of cancer associated CTCF mutations to investigate CTCFs role in regulating imprinted regions and their contribution to cancer
TYPE: NEW GRANT
He Eric Zhu, Ph.D.
Dana-Farber Cancer Institute, Boston MA PROJECT: Global Ubiquitome Profiling by Transpeptidation Aided Mass Spectrometry (TAMS) to Decipher the Ubiquitin Signaling of USP7 in Ewing sarcoma
TYPE: RENEWAL
Past Beneficiaries
Jiao Li, PhD.
Dana-Farber Cancer Institute
PROJECT: Characterization of a Novel Cell-Surface Therapeutic Target in Translocation Renal Cell Carcinoma
2021-2022
Pei-Chi Wei
Boston Children’s Hospital
PROJECT: Investigate the contribution of DNA double strand breaks to recurrent genomic alterations in medulloblastomas
2015
Mireia Perez Verdaguer, Ph.D.
University of Pittsburgh School of Medicine
PROJECT: Improving the Tumor-Suppressing Efficacy of EGFR Antibodies on Head-and-Neck Squamous Cell Carcinoma
2020-2022
Yuanyuan Li, Ph.D.
NYU School of Medicine
New York, NY
PROJECT:
Role of CTCF Mutations in Altering Nuclear Architecture and Gene Regulation in Cancer
2019-2020
Marie Menard, Ph.D.
Univ of California, San Francisco
PROJECT: Generation of a stem cell-based preclinical model for high-risk Neuroblastoma to test combinations of targeted therapies and immunotherapy
2018-2017
Carmen Adriaens, Ph.D.
Massachusetts General Hospital
Boston, MA
PROJECT:
Targeting DMNT1 to induce anti-cancer gene expression programs and synthetic lethality
2021-2023
Wei-Chien Yuan, Ph.D.
Boston Children’s Hospital, Boston MA
PROJECT: In Vivo Systematic Characterization of Hippe-YAP Oncogenic Targets
2015-2016
Haopeng Xiao, Ph.D.
Dana-Farber Cancer Institute
PROJECT: Proteomic approaches to investigate Redox control in cancer
2019-2021
Liying Chen, Ph.D.
Dana-Farber Cancer Institute
PROJECT: The Role of ZEpigenetic Modifier EZH2 in MYCN-amplified Neuroblastoma
2017
